Table 1 Univariable and multivariable analysis of clinical features

Sex(female/male)

1. 113

1. 022

1. 212

 < 0. 05

1. 132

1. 034

1. 24

 < 0. 05

Age(mean ± SD)

1. 004

1. 001

1. 008

 < 0. 05

1. 005

1. 001

1. 008

 < 0. 05

Hematuria

(absent/present)

1. 311

1. 14

1. 508

 < 0. 05

1. 161

1. 011

1. 332

0. 075

Abdominalpain

(absent/present)

1. 071

0. 969

1. 184

0. 258

Abdominalmass

(absent/present)

0. 947

0. 685

1. 31

0. 784

Tumorhistory

(absent/present)

1. 207

1. 026

1. 419

0. 056

Location

(left/right)

1. 039

0. 958

1. 127

0. 435

eGFR

(ml/(min·1. 73 m2))

0. 998

0. 995

1. 001

0. 188

BUN(mmol/L)

1. 025

1. 001

1. 049

0. 085

Cr(umol/L)

1

0. 999

1. 001

0. 773

CHO(mmol/L)

0. 957

0. 908

1. 009

0. 169

ALB(g/L)

0. 988

0. 979

0. 996

 < 0. 05

0. 998

0. 989

1. 007

0. 683

Hb(g/L)

0. 996

0. 994

0. 999

 < 0. 05

0. 999

0. 996

1. 002

0. 6

PLT(g/L)

1. 001

1. 001

1. 002

 < 0. 05

1. 001

1

1. 002

 < 0. 05

NE(10 × 10^9)

1. 037

1. 012

1. 063

 < 0. 05

1. 001

0. 975

1. 026

0. 974

LYM(10 × 10^9)

1. 021

0. 989

1. 055

0. 285

MO(10 × 10^9)

1. 185

0. 956

1. 471

0. 194

R(mm)

1. 004

1. 002

1. 006

 < 0. 05

1. 001

0. 999

1. 003

0. 621

E

0. 961

0. 896

1. 031

0. 358

N

1. 099

1. 042

1. 16

 < 0. 05

1. 067

0. 992

1. 147

0. 142

A

1. 064

1. 013

1. 116

 < 0. 05

1. 009

0. 963

1. 059

0. 745

L

1. 071

1. 02

1. 125

 < 0. 05

0. 995

0. 931

1. 063

0. 895

H(no/yes)

1. 376

1. 239

1. 528

 < 0. 05

1. 168

1. 022

1. 335

0. 056

Renal_score

1. 051

1. 028

1. 074

 < 0. 05

1. 005

0. 966

1. 046

0. 848

Map1

1. 002

0. 944

1. 063

0. 965

Map2

1. 047

1. 01

1. 084

 < 0. 05

0. 984

0. 946

1. 022

0. 488

Map_score

1. 027

0. 998

1. 055

0. 128

Cystic

(absent/present)

0. 963

0. 868

1. 068

0. 552

Capsule

(absent/present)

1. 014

0. 929

1. 108

0. 79

MVD(absent/present)

1. 016

0. 932

1. 106

0. 765

Calcification

(absent/present)

1. 127

1. 015

1. 251

0. 061

^{Invasion(no/yes)}

1. 39

1. 247

1. 548

 < 0. 05

1. 097

0. 96

1. 255

0. 254

Cavainvolvement

(absent/present)

1. 373

1. 165

1. 618

 < 0. 05

1. 032

0. 85

1. 254

0. 79

Lymphnodes

(absent/present)

1. 459

1. 194

1. 784

 < 0. 05

1. 054

0. 831

1. 338

0. 715

Metastasis(absent/present)

2. 136

1. 556

2. 933

 < 0. 05

1. 277

0. 894

1. 824

0. 259

Enhancement1

(heterogeneous/homogeneous)

1. 121

0. 972

1. 292

0. 186

Enhancement2(absent/present)

0. 924

0. 847

1. 007

0. 132